Gain Therapeutics (GANX)
US Market

Gain Therapeutics (GANX) Financial Statements


Gain Therapeutics Financial Overview

Gain Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.635; its P/E ratio is -3.01; Gain Therapeutics is scheduled to report earnings on August 8, 2023, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 55.18K-$ 0.00$ 95.10K$ 45.01K
Gross Profit$ 55.18K----
EBIT$ -5.27M$ -4.76M$ -4.75M$ -5.18M$ -3.29M
EBITDA$ -5.25M$ -4.74M$ -4.73M$ -5.16M$ -3.28M
Net Income Common Stockholders$ -5.14M$ -4.67M$ -4.56M$ -5.09M$ -3.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 17.82M$ 20.14M$ 22.73M$ 24.25M$ 34.34M
Total Assets$ 21.18M$ 24.10M$ 28.33M$ 31.89M$ 37.60M
Total Debt$ 1.21M$ 1.27M$ 1.27M$ 1.39M$ 1.50M
Net Debt$ -16.61M$ -18.86M$ -21.46M$ -22.86M$ -32.84M
Total Liabilities$ 6.17M$ 5.22M$ 5.66M$ 4.87M$ 5.77M
Stockholders Equity$ 15.14M$ 18.88M$ 22.66M$ 27.02M$ 31.83M
Cash Flow-
Free Cash Flow$ -4.23M$ -3.91M$ -3.35M$ -5.10M$ -2.46M
Operating Cash Flow$ -4.22M$ -3.90M$ -3.29M$ -5.05M$ -2.45M
Investing Cash Flow$ 2.11M$ 133.83K$ -11.41K$ -14.89M$ -7.83K
Financing Cash Flow$ 748.91K$ -21.58K$ -20.58K$ 1.36K$ -37.97K
Currency in USD

Gain Therapeutics Earnings and Revenue History

Gain Therapeutics Debt to Assets

Gain Therapeutics Cash Flow

Gain Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis